Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500
Closed -$238K 77
2025
Q3
$238K Hold
500
0.09% 68
2025
Q2
$235K Buy
+500
New +$228K 0.09% 71
2025
Q1
Sell
-500
Closed -$209K 70
2024
Q4
$209K Buy
+500
New +$228K 0.09% 70
2024
Q3
Sell
-500
Closed -$219K 76
2024
Q2
$219K Hold
500
0.09% 64
2024
Q1
$232K Hold
500
0.1% 66
2023
Q4
$205K Buy
+500
New +$197K 0.11% 70
2019
Q4
Sell
-1,600
Closed -$310K 74
2019
Q3
$310K Buy
+1,600
New +$310K 0.24% 58

Other funds holding LIN

Geneva Partners's LIN Position: Q4 2025 in Review

Geneva Partners sold out of Linde (LIN) in Q4 2025, closing a stake of 500 shares — an estimated $238K sold.

Geneva Partners first reported a position in LIN in Q3 2019 and held it in 7 quarters. The position peaked at $310K in Q3 2019. 2,127 funds tracked by Wall St. Rank hold LIN as of Q4 2025.

  • Geneva Partners reported no remaining Linde position as of Q4 2025 after selling out during the quarter.
  • Geneva Partners sold 500 Linde shares in Q4 2025, an estimated $238K.
  • Geneva Partners first reported a position in Linde in Q3 2019 and held it in 7 quarters.
  • Geneva Partners's Linde position peaked at $310K in Q3 2019.
  • 2,127 funds tracked by Wall St. Rank held Linde as of Q4 2025.

Based on Geneva Partners's 13F filing for Q4 2025, filed 3 Feb 2026.